CORONA Remedies appoints four Independent Directors to its board

Ahmedabad: CORONA Remedies Limited, backed by Sepia Investments Limited, an affiliate of ChrysCapital, has appointed Ameetkumar Hiranyakumar Desai, Bhaskar Vemban Iyer, Shirish Gundopant Belapure and Monica Hemal Kanuga as Independent Directors to its Board of Directors bringing in diverse expertise and experience.

Ameet is founder and director of Anubhuti Advisory LLP. He has distinguished career spanning more than 35 years with India Inc. He has an extensive experience in Treasury, Investment Management and Corporate Finance. He was the Executive Director and group CFO with Adani Group. Ameet was Global Head of M&A and Business Planning for Ranbaxy Laboratories Ltd., the largest Indian pharmaceutical company.

Bhasker is a strategic business leader with over four decades of experience in the pharmaceutical and healthcare industry spanning country management, global leadership and Board Directorship roles. Prior to joining Advent as an Operating Partner in a specialist advisory capacity, Bhasker was a Corporate Officer with Abbott for the India region, leading sales, manufacturing and R&D operations for the healthcare MNC in India. He has held global leadership positions with Wockhardt in India and AstraZeneca in Asia-Pacific based in Singapore and country management positions in AstraZeneca, Nicholas Piramal India Limited, ICI Pharmaceuticals and senior roles in Glaxo India Limited. He is also a Director, Value Optimisation Board for Quadria Capital, a healthcare focused PE firm. He is also an Independent Director on the Boards of RPG Life Science, Cohance Lifesciences Ltd, and Themis Medicare Ltd. He is also Director at Quadria Capital, a private equity firm.

Shirish is a Senior Technical Advisor with Indian Pharmaceutical Alliance since April ‘19. He has an experience of managing operations in Pharmaceuticals in the wide range of areas like formulations/Api manufacturing & development, Quality Assurance, Regulatory affairs for about 42 years. He is also Venture Partner with “Eight Roads”, a private equity firm. He was also president of PDA India chapter for two years from Dec ‘19 to Nov ’21. Prior to this, he was Managing Director of Zydus Hospira Oncology Pvt Ltd- a joint venture company between Zydus & Pfizer. Earlier experience includes working as President (Global Manufacturing) and was responsible for entire manufacturing network of Formulations and Projects globally for Zydus Cadila. In addition to this, he has also worked with Sun Pharma, Cipla, Lederle to name a few, in various capacities. He was associated with Nirma University as a member of board of studies. He is also on the board of directors in multiple companies to name a few, Albert David, Jubiliant Pharmanova etc.